These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 30499006)

  • 41. Low shear stress upregulates the expression of fractalkine through the activation of mitogen-activated protein kinases in endothelial cells.
    Ruze A; Zhao Y; Li H; Gulireba X; Li J; Lei D; Dai H; Wu J; Zhao X; Nie Y
    Blood Coagul Fibrinolysis; 2018 Jun; 29(4):361-368. PubMed ID: 29406386
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Fractalkine/CX3CR1 axis modulated the development of pancreatic ductal adenocarcinoma via JAK/STAT signaling pathway.
    Huang L; Ma B; Ma J; Wang F
    Biochem Biophys Res Commun; 2017 Dec; 493(4):1510-1517. PubMed ID: 28986258
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Increase of serum fractalkine and fractalkine gene expression levels in sickle cell disease patients.
    Unal S; Ozdemir O; Ozcimen AA; Oztas Y
    Int J Hematol; 2015 Feb; 101(2):114-8. PubMed ID: 25480631
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fractalkine stimulates cell growth and increases its expression via NF-κB pathway in RA-FLS.
    Guo X; Pan Y; Xiao C; Wu Y; Cai D; Gu J
    Int J Rheum Dis; 2012 Jun; 15(3):322-9. PubMed ID: 22709495
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potential significance of CX3CR1 dynamics in stress resilience against neuronal disorders.
    Inoue K
    Neural Regen Res; 2022 Oct; 17(10):2153-2156. PubMed ID: 35259822
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hippocampal T cell infiltration promotes neuroinflammation and cognitive decline in a mouse model of tauopathy.
    Laurent C; Dorothée G; Hunot S; Martin E; Monnet Y; Duchamp M; Dong Y; Légeron FP; Leboucher A; Burnouf S; Faivre E; Carvalho K; Caillierez R; Zommer N; Demeyer D; Jouy N; Sazdovitch V; Schraen-Maschke S; Delarasse C; Buée L; Blum D
    Brain; 2017 Jan; 140(1):184-200. PubMed ID: 27818384
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Reduced inflammatory and neuropathic pain and decreased spinal microglial response in fractalkine receptor (CX3CR1) knockout mice.
    Staniland AA; Clark AK; Wodarski R; Sasso O; Maione F; D'Acquisto F; Malcangio M
    J Neurochem; 2010 Aug; 114(4):1143-57. PubMed ID: 20524966
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Age-dependent changes on fractalkine forms and their contribution to neurodegenerative diseases.
    Eugenín J; Eugenín-von Bernhardi L; von Bernhardi R
    Front Mol Neurosci; 2023; 16():1249320. PubMed ID: 37818457
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Early depletion of CA1 neurons and late neurodegeneration in a mouse tauopathy model.
    Helboe L; Egebjerg J; Barkholt P; Volbracht C
    Brain Res; 2017 Jun; 1665():22-35. PubMed ID: 28411086
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model.
    Zhang B; Yao Y; Cornec AS; Oukoloff K; James MJ; Koivula P; Trojanowski JQ; Smith AB; Lee VM; Ballatore C; Brunden KR
    Mol Neurodegener; 2018 Nov; 13(1):59. PubMed ID: 30404654
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Functional networks are impaired by elevated tau-protein but reversible in a regulatable Alzheimer's disease mouse model.
    Green C; Sydow A; Vogel S; Anglada-Huguet M; Wiedermann D; Mandelkow E; Mandelkow EM; Hoehn M
    Mol Neurodegener; 2019 Mar; 14(1):13. PubMed ID: 30917861
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Novel Lipidized Analog of Prolactin-Releasing Peptide Improves Memory Impairment and Attenuates Hyperphosphorylation of Tau Protein in a Mouse Model of Tauopathy.
    Popelová A; Pražienková V; Neprašová B; Kasperová BJ; Hrubá L; Holubová M; Zemenová J; Blum D; Železná B; Galas MC; Kuneš J; Maletínská L
    J Alzheimers Dis; 2018; 62(4):1725-1736. PubMed ID: 29614684
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recruitment of CD16(+) monocytes to endothelial cells in response to LPS-treatment and concomitant TNF release is regulated by CX3CR1 and interfered by soluble fractalkine.
    Rennert K; Heisig K; Groeger M; Wallert M; Funke H; Lorkowski S; Huber O; Mosig AS
    Cytokine; 2016 Jul; 83():41-52. PubMed ID: 27031442
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Riluzole rescues glutamate alterations, cognitive deficits, and tau pathology associated with P301L tau expression.
    Hunsberger HC; Weitzner DS; Rudy CC; Hickman JE; Libell EM; Speer RR; Gerhardt GA; Reed MN
    J Neurochem; 2015 Oct; 135(2):381-94. PubMed ID: 26146790
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/lpr mice.
    Inoue A; Hasegawa H; Kohno M; Ito MR; Terada M; Imai T; Yoshie O; Nose M; Fujita S
    Arthritis Rheum; 2005 May; 52(5):1522-33. PubMed ID: 15880599
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhanced recruitment of CX3CR1+ T cells by mucosal endothelial cell-derived fractalkine in inflammatory bowel disease.
    Sans M; Danese S; de la Motte C; de Souza HS; Rivera-Reyes BM; West GA; Phillips M; Katz JA; Fiocchi C
    Gastroenterology; 2007 Jan; 132(1):139-53. PubMed ID: 17241867
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The complex role of the chemokine CX3CL1/Fractalkine in major depressive disorder: A narrative review of preclinical and clinical studies.
    Bridge S; Karagiannis SN; Borsini A
    Brain Behav Immun Health; 2024 Jul; 38():100778. PubMed ID: 38706575
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Fractalkine Signaling Regulates the Inflammatory Response in an α-Synuclein Model of Parkinson Disease.
    Thome AD; Standaert DG; Harms AS
    PLoS One; 2015; 10(10):e0140566. PubMed ID: 26469270
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TREM2 deficiency attenuates neuroinflammation and protects against neurodegeneration in a mouse model of tauopathy.
    Leyns CEG; Ulrich JD; Finn MB; Stewart FR; Koscal LJ; Remolina Serrano J; Robinson GO; Anderson E; Colonna M; Holtzman DM
    Proc Natl Acad Sci U S A; 2017 Oct; 114(43):11524-11529. PubMed ID: 29073081
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fractalkine promotes chemotaxis of bone marrow-derived mesenchymal stem cells towards ischemic brain lesions through Jak2 signaling and cytoskeletal reorganization.
    Zhang Y; Zheng J; Zhou Z; Zhou H; Wang Y; Gong Z; Zhu J
    FEBS J; 2015 Mar; 282(5):891-903. PubMed ID: 25559502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.